GL1X · GenesisL1 explorer

Research workbench

Activation of the human nuclear xenobiotic receptor pxr by the reverse transcriptase-targeted anti-HIV drug pnu-142721

Analyse Activation of the human nuclear xenobiotic receptor pxr by the reverse… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3R8D
Type
protein
Length
264 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor subfamily 1 group I member 2
EC
2.3.1.48
UniProt
O75469
Ligands
PNU
Pockets
2 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 56% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor subfamily 1 group I member 2 (EC 2.3.1.48)protein26456% helix, 8% strandO75469

Ligands and binding sites

  • PNU · 6-chloro-2-(1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15540.840.8960PNU
2770.350.7616empty

Compared structures

  • 3R8D · Activation of the Human Nuclear Xenobiotic Receptor PXR by the Reverse… · the same entry in another collection · chain A against A, TM-score 1.00
  • O75469 · AlphaFold monomer V2.0 prediction for nuclear receptor subfamily 1 group I member 2… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.